PP
CLBT icon

Pertento Partners’s Cellebrite CLBT Stock Holding History

Pertento Partners’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$91.8M Buy
6,662,654
+703,330
+12% +$10.6M 6.72% 5
2025
Q4 		$107M Buy
5,959,324
+1,311,109
+28% +$23.5M 10.09% 3
2025
Q3 		$86.1M Buy
4,648,215
+1,702,574
+58% +$26.7M 9.99% 3
2025
Q2 		$47.1M Buy
2,945,641
+309,988
+12% +$5.53M 4.22% 9
2025
Q1 		$51.2M Sell
2,635,653
-339,721
-11% -$7.15M 5.36% 8
2024
Q4 		$65.5M Buy
2,975,374
+626,373
+27% +$12.1M 5.55% 4
2024
Q3 		$39.6M Buy
+2,349,001
New +$34.9M 4.36% 12

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Pertento Partners's CLBT Position: Q1 2026 in Review

Pertento Partners increased its Cellebrite (CLBT) stake by 12% in Q1 2026, buying an estimated $10.6M and bringing the position to 6,662,654 shares worth $91.8M. The position accounts for 6.72% of the portfolio, ranked #5.

Pertento Partners first reported a position in CLBT in Q3 2024 and has held it in 7 quarters since. The position peaked at $107M in Q4 2025. 220 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Pertento Partners held 6,662,654 shares of Cellebrite worth $91.8M as of Q1 2026.
  • Pertento Partners bought 703,330 Cellebrite shares in Q1 2026, an estimated $10.6M.
  • Cellebrite made up 6.72% of Pertento Partners's portfolio in Q1 2026, its #5 holding.
  • Pertento Partners first reported a position in Cellebrite in Q3 2024 and has held it in 7 quarters since.
  • Pertento Partners's Cellebrite position peaked at $107M in Q4 2025.
  • 220 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Pertento Partners's 13F filing for Q1 2026, filed 14 May 2026.